Circle's new Arc blockchain, launched in September 2026, uses its USDC stablecoin to enable near-instant, 24/7 settlement of securities lending and repo trades, reducing failures and idle capital. By tokenizing collateral and removing traditional banking cutoffs, Arc aims to streamline a typically slow, legacy process. With over 100 institutional partners and a collaboration with DTCC, Circle is positioning Arc as a modern infrastructure for financial institutions. Key future indicators include live tokenized securities on Arc, growth in repo activity, and USDC circulation expansion.
Circle's Kris Gower and the Arc blockchain with USDC provide context for cryptocurrency market activity. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Nov 07, 2026 02:31 WIB: out of 50 priced major cryptocurrencies, 35 rose and 14 fell. Notable movers include SXP at Rp37 with a 1-day change of -46.27%, BAL at Rp16.297 up 11.14%, and XTZ at Rp5.016 up 8.50%, with XTZ showing a Pluang order activity of 34% Sell and 66% Buy.
The music duo for KING + COUNTRY released the Drummer Boy (Original Motion Picture Soundtrack) to coincide with the nationwide launch of their Christmas film DRUMMER BOY. The soundtrack features original songs by Joel and Luke Smallbone, reimagined C...
HMG Strategy is holding its first Tennessee C-Level Technology Leadership Summit on November 13 at W Nashville, bringing together CIOs, CISOs, CTOs, and senior tech executives from across Tennessee and the Mid-South. The summit will focus on AI, cybe...
Ipsen has disclosed its monthly update on the total number of shares and voting rights as of October 31, 2026. The company reported 83,814,526 shares composing the share capital, with a gross total of 132,059,377 voting rights and a net total of 130,...
At its 2026 International User Summit, Chery unveiled its Globalization 3.0 strategy, moving beyond export-driven growth to emphasize deep localization, sustainable development, and community engagement. The company is expanding local R&D, manufactur...
Ipsen Pharma has disclosed the total number of shares and voting rights composing its capital as of October 31, 2026. The company reported 83,814,526 shares and a gross total of 132,059,377 voting rights, with a net total of 130,677,690 after excludi...
